InsidersTradesSigma
Track the 큐리언트 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 큐리언트 has recorded 11 public disclosures. Market capitalisation: €640.2bn. The latest transaction was filed on 23 June 2026 (Sale). Among the most active insiders: 유암코키스톤구조혁신기업재무안정사모투자. All data is accessible without an account.
8
Insider Decl.
n/a
Thresholds
€200,698
5 ops.
Buy Volume
n/a
2 ops.
Sell Volume
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,533 of 29,063 companies
16.2
score / 100
Value24
Quality9
FCF yld-4.1%
Earn yld-3.8%
EV/EBITDA·
ROE-102%
Gross mgn13%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 June 2026
Declarations11 total
Other
Other
Other
2,000 sharesKRXDART:20260623000267
11 of 11 declarations
关于 큐리언트
큐리언트 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于开发针对各种疾病的创新疗法。